IR-MED Ltd. Announces Launch of First-in-Human Clinical Trial of Its DiaSafe(TM) Device for Diabetic Foot Ulcer (DFU) Assessment
Rosh Pina, Israel--(Newsfile Corp. - November 3, 2025) - IR-MED Ltd. (OTCQB: IRME) (the "Company" or "IR-Med"), a pioneer in artificial intelligence ("AI")-driven, non-invasive infrared spectrographic medical device develop
Technology, Biotechnology, Healthcare and Hospitals, Health
2025-11-03 4:30 PM EST | IR-MED, Inc.
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds
King of Prussia, Pennsylvania--(Newsfile Corp. - November 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer, today announced the entry into definitive agreements to exercise certain outstanding warrants to purchase up to an aggregate of 5,663,182 shares of common stock of the Company originally issued in July 2024, December 2024, Januar
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-11-03 1:40 PM EST | Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial
King of Prussia, Pennsylvania--(Newsfile Corp. - November 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-11-03 7:45 AM EST | Phio Pharmaceuticals Corp.
Conexeu Sciences Appoints Miles Harrison as President & Chief Executive Officer, to Shape the Future of True Tissue Regeneration
Reno, Nevada--(Newsfile Corp. - November 3, 2025) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a pre-commercial biotechnology company redefining regenerative medicine through next-generation collagen science, announces the appointment of Miles D. Harrison as President & Chief Executive Officer of the Company. He has also been appointed to the Company's Board of Directors. At Conexeu, Miles will lead the Company's next phase of growth, advancing its first-in-class col
Healthcare and Hospitals, Pharmaceuticals, Health
2025-11-03 7:00 AM EST | Conexeu Sciences Inc.
Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug
Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bacteria and viruses, is pleased to share a scientific poster which demonstrates the effectiveness of X-Ray-activated Rutherrin® for numerous cancer
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2025-11-03 7:00 AM EST | Theralase Technologies Inc.
HEALWELL AI Announces Strategic Divestments and Progression to a Pure-Play SaaS, Services and AI Business
HEALWELL has divested its Polyclinic Family Medicine and Specialty Group of Clinics to WELL Health Clinic Network Inc. ("WELL Clinics"), who has been previously managing these clinics for HEALWELL since January 2024. HEALWELL has sold its interest in Mutuo Health Solutions Inc. ("Mutuo") to WELLSTAR Technologies Corp. ("WELLSTAR"), so it can better focus on its large enterprise healthcare software and AI business. Mutuo is prima
Technology, Healthcare and Hospitals
2025-11-03 3:15 AM EST | HEALWELL AI
Cosmo Receives CE Certification for ColonPRO EU - The Most Advanced AI Software Platform for Colonoscopy in Europe
Dublin, Ireland--(Newsfile Corp. - November 3, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that ColonPRO EU, the Company’s next-generation artificial intelligence software for colonoscopy, has received CE certification. Following FDA clearance in the United States, this certification brings to Europe the most advanced AI-assisted colonoscopy platform ever developed. The system has already
Healthcare and Hospitals, Health
2025-11-03 12:59 AM EST | Cosmo Pharmaceuticals N.V.
Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director
King of Prussia, Pennsylvania--(Newsfile Corp. - October 31, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio is pleased to announce that David Deming has been appointed Lead Independent Director of the Board of Directors of Phio Pharmaceuticals. Mr. Deming brings over 30 years of experience in investment bankin
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-10-31 10:15 AM EDT | Phio Pharmaceuticals Corp.
Anne-Kathrin Stoller to Become New CEO at Bachem
Bubendorf, Switzerland--(Newsfile Corp. - October 31, 2025) - Ad hoc announcement pursuant to Art. 53 LR Anne-Kathrin Stoller to become new CEO at Bachem Bachem (SIX: BANB) announced today that its Board of Directors has appointed Anne-Kathrin Stoller, currently Head of Bachem Americas and previously the company's long-standing Chief Marketing Officer (CMO), as its new CEO, effective January 1, 2026. She succeeds Thomas Meier, wh
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2025-10-31 2:23 AM EDT | Bachem Holding AG
HEALWELL's Orion Health Signs Memorandum of Understanding with Lean Business Services to Advance AI-Powered Healthcare in Saudi Arabia & Across the Middle East
HEALWELL AI and its subsidiary Orion Health have signed a Memorandum of Understanding (MoU) with Lean Business Services, to jointly explore the development and commercialization of digital health and AI-driven solutions across the Middle East and Orion's global markets. The MoU leverages complementary strengths across technology, innovation, and market access, focusing on AI driven population health, clinical AI, and data-interoperability. I
Technology, Healthcare and Hospitals
2025-10-30 3:15 AM EDT | HEALWELL AI
Ivey Business School and Governance Professionals of Canada Launch Premier Executive Program for Governance Professionals and Executives Shaping the Future of Board Leadership
Toronto, Ontario--(Newsfile Corp. - October 29, 2025) - A novel executive education program from Ivey Business School and the Governance Professionals of Canada (GPC) is setting a new standard in strategic governance leadership. The Ivey-GPC Governance Leadership Program is designed for the senior governance professionals, executives, and directors reshaping how modern boards navigate in an increasingly complex global landscape. Against tough economic headwinds, geopolitical vol
Banking / Financial Services, Education, Healthcare and Hospitals, Oil & Gas
2025-10-29 1:00 PM EDT | Governance Professionals of Canada
KATALYST & Co. Healthcare Transformation Platform Launches with $10 Million in Funding
Palm Beach, Florida--(Newsfile Corp. - October 29, 2025) - Kat Marie Alvarez, RN, MBA, a nationally recognized healthcare leader, today announced the launch of KATALYST & Co., an integrated platform that unites strategic advisory services, capital deployment, and global operational execution. The company begins operations with $10 million in funding to drive its mi
Healthcare and Hospitals, Insurance, Investment Banking, Health
2025-10-29 8:30 AM EDT | KATALYST & Co.
Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant
White Bear Lake, Minnesota--(Newsfile Corp. - October 29, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the three-year anniversary of the first patient receiving its breakthrough first fully implanted cochlear implant. On October 24, 2022, Craig Eggert became the first patient in the world to be implanted with Envoy Medical's new investigational fully implanted cochlear impl
Biotechnology, Healthcare and Hospitals
2025-10-29 8:00 AM EDT | Envoy Medical, Inc.
Discovery Senior Living Expands Seaton Senior Living Regional Management Company; Appoints Divisional Chief Operating Officer to Lead Next Phase of Mid-Atlantic Growth
Bonita Springs, Florida--(Newsfile Corp. - October 28, 2025) - Discovery Senior Living ("Discovery", or the "Company") and its affiliated management companies, one of the most trusted and the largest privately held senior housing operators in the US, is pleased to announce the expansion of its newest regional Management Company, Seaton Senior Living ("Seaton"), reinforcing the Company's growing presence and scale across the Mid-Atlantic region. Seaton's expansion is driven by strong po
Healthcare and Hospitals, Real Estate, Housing
2025-10-28 10:01 AM EDT | Discovery Senior Living
Adia Nutrition Thrilled to Announce to Shareholders Early Q3 Financials Release and Remarkable 200%+ Revenue Growth
Winter Park, Florida--(Newsfile Corp. - October 28, 2025) - Adia Nutrition (OTCQB: ADIA) is thrilled to announce the early release of its Q3 financial results, a powerful testament to the exceptional organization and unwavering commitment of our dynamic team. By unveiling these results weeks ahead of schedule, Adia Nutrition reinforces its dedication to transparency, operational excellence, and industry leadership, while delivering a financial performance that redefines success. Adia Nu
Healthcare and Hospitals, Health
2025-10-28 9:30 AM EDT | Adia Nutrition Inc.
HEALWELL AI to Announce Fiscal Third Quarter 2025 Financial Results on November 6, 2025
Toronto, Ontario--(Newsfile Corp. - October 27, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to ann
Technology, Healthcare and Hospitals
2025-10-27 5:08 PM EDT | HEALWELL AI
IR-MED's Key Clinical and Media Milestones
Rosh Pina, Israel--(Newsfile Corp. - October 27, 2025) - IR-Med Inc. (OTCQB: IRME), (the "Company" or "IR-Med"), a medical technology company developing a non-invasive, AI-powered infrared spectroscopy platform for the assessment of pressure injuries and diabetic ulcers, today announced a series of recent milestones that highlight the Company's expanding visibility within the healthcare, investment, and media communities. Podium Presentation at Magnet & Pathway 2025 Confer
Technology, Biotechnology, Healthcare and Hospitals, Health
2025-10-27 4:05 PM EDT | IR-MED, Inc.
Wellgistics Health Enters into Smart Contract Services Agreement with DataVault AI to Develop Patented PharmacyChain(TM) Manufacturer-to-Patient Blockchain-Enabled Tracking & Dispensing Platform for Prescription Drug Market
Florida and Philadelphia, Pennsylvania--(Newsfile Corp. - October 27, 2025) - Wellgistics Health, Inc. (NASDAQ: WGRX) ("Wellgistics"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that it has entered into a software as a service (SAAS) agreement with DataVault AI, Inc. (NASDAQ: DVLT) ("DataVault"), a pioneering technology company leading the way in AI data experie
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Blockchain
2025-10-27 9:42 AM EDT | Wellgistics Health
Envoy Medical Receives Positive Listing Determination from NASDAQ
White Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that the Nasdaq Hearings Panel (the "Panel) has granted the Company's request for continued listing on the Nasdaq Stock Market. In granting the extension, the Panel considered several key developments, including Envoy Medical's recent equity capital raises and debt e
Biotechnology, Healthcare and Hospitals
2025-10-27 8:00 AM EDT | Envoy Medical, Inc.
HEALWELL Files Amended Business Acquisition Report
Toronto, Ontario--(Newsfile Corp. - October 24, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, announces it has filed an amended and restated business acquisition report dated October 24, 2025 (the "Amended BAR"), relating to HEALWELL's acquisition of Orion Health Holdings Limited which closed on April 1, 2025. The Amended BAR replaces and supersedes the previous
Technology, Healthcare and Hospitals
2025-10-24 7:06 PM EDT | HEALWELL AI